BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 1987766)

  • 1. Urinary excretion of the C5b-9 membrane attack complex of complement is a marker of immune disease activity in autologous immune complex nephritis.
    Pruchno CJ; Burns MM; Schulze M; Johnson RJ; Baker PJ; Alpers CE; Couser WG
    Am J Pathol; 1991 Jan; 138(1):203-11. PubMed ID: 1987766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased urinary excretion of C5b-9 distinguishes passive Heymann nephritis in the rat.
    Schulze M; Baker PJ; Perkinson DT; Johnson RJ; Ochi RF; Stahl RA; Couser WG
    Kidney Int; 1989 Jan; 35(1):60-8. PubMed ID: 2651753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary excretion of C5b-9 reflects disease activity in passive Heymann nephritis.
    Pruchno CJ; Burns MW; Schulze M; Johnson RJ; Baker PJ; Couser WG
    Kidney Int; 1989 Jul; 36(1):65-71. PubMed ID: 2681928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcellular transport and membrane insertion of the C5b-9 membrane attack complex of complement by glomerular epithelial cells in experimental membranous nephropathy.
    Kerjaschki D; Schulze M; Binder S; Kain R; Ojha PP; Susani M; Horvat R; Baker PJ; Couser WG
    J Immunol; 1989 Jul; 143(2):546-52. PubMed ID: 2738403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of passive Heymann nephritis in complement component 6-deficient PVG rats.
    Spicer ST; Tran GT; Killingsworth MC; Carter N; Power DA; Paizis K; Boyd R; Hodgkinson SJ; Hall BM
    J Immunol; 2007 Jul; 179(1):172-8. PubMed ID: 17579035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of aminonucleoside nephrosis on immune complex localization in autologous immune complex nephropathy in rats.
    Couser WG; Jermanovich NB; Belok S; Stilmant MM; Hoyer JR
    J Clin Invest; 1978 Mar; 61(3):561-72. PubMed ID: 147884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated urinary excretion of the C5b-9 complex in membranous nephropathy.
    Schulze M; Donadio JV; Pruchno CJ; Baker PJ; Johnson RJ; Stahl RA; Watkins S; Martin DC; Wurzner R; Gotze O
    Kidney Int; 1991 Sep; 40(3):533-8. PubMed ID: 1787650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determinants of glomerular localization of subepithelial immune deposits: effects of altered antigen to antibody ratio, steroids, vasoactive amine antagonists, and aminonucleoside of puromycin on passive Heymann nephritis in rats.
    Salant DJ; Belok S; Stilmant MM; Darby C; Couser WG
    Lab Invest; 1979 Jul; 41(1):89-99. PubMed ID: 376941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal C3 synthesis in idiopathic membranous nephropathy: correlation to urinary C5b-9 excretion.
    Montinaro V; Lopez A; Monno R; Cappiello V; Manno C; Gesualdo L; Schena FP
    Kidney Int; 2000 Jan; 57(1):137-46. PubMed ID: 10620195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The membrane attack complex in complement-mediated glomerular epithelial cell injury: formation and stability of C5b-9 and C5b-7 in rat membranous nephropathy.
    Cybulsky AV; Quigg RJ; Salant DJ
    J Immunol; 1986 Sep; 137(5):1511-6. PubMed ID: 3745914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Depletion of C6 prevents development of proteinuria in experimental membranous nephropathy in rats.
    Baker PJ; Ochi RF; Schulze M; Johnson RJ; Campbell C; Couser WG
    Am J Pathol; 1989 Jul; 135(1):185-94. PubMed ID: 2672823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibodies to glycolipids activate complement and promote proteinuria in passive Heymann nephritis.
    Susani M; Schulze M; Exner M; Kerjaschki D
    Am J Pathol; 1994 Apr; 144(4):807-19. PubMed ID: 8160779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new role for complement in experimental membranous nephropathy in rats.
    Salant DJ; Belok S; Madaio MP; Couser WG
    J Clin Invest; 1980 Dec; 66(6):1339-50. PubMed ID: 7440718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary C3dg and C5b-9 indicate active immune disease in human membranous nephropathy.
    Brenchley PE; Coupes B; Short CD; O'Donoghue DJ; Ballardie FW; Mallick NP
    Kidney Int; 1992 Apr; 41(4):933-7. PubMed ID: 1387434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autologous immune complex nephropathy. I. Sequential study of immune complex deposition, ultrastructural changes, proteinuria, and alterations in glomerular sialoprotein.
    Couser WG; Stilmant MM; Darby C
    Lab Invest; 1976 Jan; 34(1):23-30. PubMed ID: 1246122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Membrane attack complex deposition in experimental glomerular injury.
    Perkinson DT; Baker PJ; Couser WG; Johnson RJ; Adler S
    Am J Pathol; 1985 Jul; 120(1):121-8. PubMed ID: 3160245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beneficial effects of systemic immunoglobulin in experimental membranous nephropathy.
    Nangaku M; Pippin J; Richardson CA; Schulze M; Young BA; Alpers CE; Gordon KL; Johnson RJ; Couser WG
    Kidney Int; 1996 Dec; 50(6):2054-62. PubMed ID: 8943490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autologous immune complex nephritis in rats. Influence of modification of mononuclear phagocyte system function.
    Abrass CK
    Lab Invest; 1984 Aug; 51(2):162-71. PubMed ID: 6611451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical study of the C5b-9 complex of complement in human kidneys.
    Hinglais N; Kazatchkine MD; Bhakdi S; Appay MD; Mandet C; Grossetete J; Bariety J
    Kidney Int; 1986 Sep; 30(3):399-410. PubMed ID: 3537447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glomerular complement regulation is overwhelmed in passive Heymann nephritis.
    Cunningham PN; Hack BK; Ren G; Minto AW; Morgan BP; Quigg RJ
    Kidney Int; 2001 Sep; 60(3):900-9. PubMed ID: 11532085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.